Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Molecular FormulaC31H33N5O2S |
InChIKeyQDWKGEFGLQMDAM-UHFFFAOYSA-N |
CAS Registry1129403-56-0 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Phase 1 | - | - |